Home
News
Create
Screeners
Insights
Vivanza Biosciences
2.
14
0.00
(0.00%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
+8.63%
6M
-11.20%
1Y
-41.53%
5Y
-65.20%
View Company Insights
Latest news about Vivanza Biosciences
Vivanza Biosciences Announces Leadership Changes and Business Expansion Plans
Nov 14, 2025
Vivanza Biosciences Limited has announced significant changes following a board meeting. CS Chaitra Arora has been appointed as the new Company Secretary and Compliance Officer, replacing CS Siddhi Shah who resigned. The company plans to expand into manufacturing and distributing plastic polymer films and packaging materials, subject to shareholder approval. For the quarter ended September 30, 2025, the company reported revenue of Rs. 373.18 lacs and profit before tax of Rs. 46.21 lacs. A postal ballot process for shareholder approval is scheduled, with results to be declared by December 18, 2025.
Vivanza Biosciences Reports Q2 Results, Appoints New Company Secretary, Plans Business Expansion
Nov 11, 2025
Vivanza Biosciences Promoter Reduces Stake by 3.07% Through Market Transaction
Oct 28, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation